Media
Publications
Genome-encoded cytoplasmic double-stranded RNAs, found inC9ORF72ALS-FTDbrain, propagate neuronal loss
Machine learning identifies candidates for drug repurposing in Alzheimer's disease
Innate immune signaling in the olfactory epithelium reduces odorant receptor levels: modeling transient smell loss in COVID-19 patients
Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia
causalCmprsk: An R package for nonparametric and Cox-based estimation of average treatment effects in competing risks data
International consensus statement on allergy and rhinology: Olfaction
At-home Smell Test Detecs Mild Cognitive Impairment
Conferences
Abstracts for ACHEMS 2024
Cross-Cultural Evaluation of Olfactory Dysfunction: Insights from a Bilingual Longitudinal At-Home Smell Test
Alysa M. Alejandro Soto, Alefiya Albers, Colin Magdamo, Beyzanur Ergun, Andreas Runde, Mark Albers
Department of Neurology, Massachusetts General Hospital, Boston, MA,
Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
Andreas Rude1, Colin Magdamo1, Alysa Alejandro Soto1, Benoit Jobin1,2, Alefiya Albers1, Mark Albers1
1Massachusetts General Hospital, Boston, MA, United States2Université du Québec à Trois-Rivières, Trois-Rivières, OC, Canada
Olfactory biomarkers associated with brain volumes and cognition in former professional American football players: results from the Harvard Football Players Health Study
Benoit Jobin1,2, Colin Magdamo2,3, Rachel Grashow4, Ona Wu2,3,5, Coby Dodelson2,5, Grant L Iverson2,3,6, Ross Zafonte2,3,6, Aaron L Baggish2, Mark W Albers2,3
1Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada2Massachusetts General Hospital, Boston, MA, United States3Harvard Medical School, Boston, MA, United States4Harvard T. H. Chan School of Public Health, Boston, MA, United States5Athinoula A Martinos Center for Biomedical Imaging, Charlestown, MA, United States6Spaulding Rehabilitation Hospital, Charlestown, MA, United States
Abstracts for EUROCIM 2024
Combining US electronic health records with weighting strategies to inform drug repurposing for dementia prevention
ML Charpignon1, Colin Magdamo2,3, Bowen Su4, Bella Vakulenko-Lagun5, Munzer Dahleh1, Anthony Philippakis6, Ioanna Tzoulaki4,7, Sudeshna Das2, Deborah Blacker8,9, Mark Albers2,3
1Institute of Data, Systems, and Society, Massachusetts Institute of Technology, 2Department of Neurology, Massachusetts General Hospital, 3Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School
4Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK 5Department of Statistics, University of Haifa, Mt Carmel Haifa, Israel, 6Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA, 7Department of Hygiene and Epidemiology, University of Ioannina, 8Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School,
9Department of Epidemiology, Harvard T.H. Chan School of Public Health
Construction of a causal inference framework for a semi-Markovian multi-state model for drug-repurposing
Alexandra Kortchemski1,2,3, Marie-Laure Charpignon4, Thibaut Horel4, Colin Magdamo1,2, Bella Vakulenko-Lagun5, Mark W. Albers1,2
1Department of Neurology, Massachusetts General Hospital, 2Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, 3CentraleSupélec, Paris-Saclay University, 4Institute of Data, Systems, and Society, Massachusetts Institute of Technology, 5Department of Statistics, University of Haifa, Mt Carmel Haifa, Israel
Website Designed By
Alyssa DeFilippis
& Developed by
Megan Tormey